このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Impact of Isolation in Patients With IBD During the COVID-19 Crisis

Impact of Isolation in Patients With IBD During the 2020 COVID-19 Crisis: a Mixed Methods Study

The coronavirus pandemic has changed healthcare dramatically in a short time. Individuals with chronic illnesses and services for them have had to adapt and change to deal with requirements for shielding and social isolation to reduce infection risk and management of medication investigation and ongoing review.

It is increasingly recognised that the pandemic and the changes to daily life will have had a series of impacts on patients and health care services, including impacts on patients psychological well-being and the opportunity to seek medical care for non-CoViD illness.

Psychological symptoms such as depression, anxiety and hopelessness is well described in adults and young people with inflammatory bowel disease. Quarantine has also been associated with these psychological symptoms and also post-traumatic stress. It is important to identify the extent of and factors that influence negative psychological consequences of isolation in patients with inflammatory bowel disease.

This study will aim to assess what impact the isolation of patients during social isolation had in terms of psychological well-being - and what are the factors affecting this impact, particularly in younger and old age groups.

調査の概要

状態

わからない

詳細な説明

This study will use both questionnaires and semi-structured interviews to understand how IBD patients have been impacted psychologically by the CoViD-19 pandemic and identify various factors that may affect the extent to which patients have been impacted. This study will also incorporate longitudinal questionnaire follow-up of the same patients, in order to try and understand the long-term impact of the pandemic, and to assess changes in psychological impact accompanying changes in the national situation.

Patients identified from those attending the IBD clinic will be contacted. As part of the NHSE and local Trust CoViD response, lists of all patients attending the IBD clinics and those deemed to be at high risk of infection have been created.

This study aims to recruit 100 patients from the high-risk group and 100 patients from the non-high-risk group. Basedon an approximately 33% response rate, we have therefore elected to identify 300 patients from the high-risk groups and 300 from non-high-risk groups. These 600 patients in total will be contacted via the post, and mailed:

  1. An explanatory cover letter, with instructions on how to participate in the study
  2. Participant information sheet (PIS)
  3. Consent form
  4. Questionnaires
  5. A stamped and addressed return envelope

Completion of questionnaire and return to site will constitute as consent for this data to be used. Postal recruitment is being used to maximise the chances of reaching those who may have been most affected by isolation and may have limited access to the internet. The consent form will apply to the optional interview component.

The PIS will include information signposting patients to help and support should they have difficulties or concerns relating to the study or the psychological impact of their condition or current situation.

Record of who has been contacted to participate will be kept on NHS computers, with patient hospital numbers corresponding to anonymous and non-identifiable study identification numbers. Keeping record will permit there to be available data regarding the questionnaire return rate. This will also potentially allow for demographic details to be retrieved from patient records regarding those who did not return responses, to facilitate both assessment of differences between responders and non-responders and provide information about those who elected not to participate.

In addition, a sub-set of 32 young people will be contacted and recruited. This sub-set have already undertaken the assessment of psychological morbidity, outlined below, during a previous, pre-CoViD outbreak study (STH20960 IRAS: 269881) and have agreed to further follow-up. These patients will also be contacted via the post to complete the same set of questionnaires and therefore provide follow-up, to assess whether measures of psychological morbidity changed following the onset of the CoViD crisis.

Patients will be asked to complete the following questionnaires:

  1. IBD symptoms: IBD control questionnaire
  2. Experience during the CoViD periods of isolation
  3. Impact of event scale (iES-15 questionnaire)
  4. Depression Anxiety Stress Scale-21 (DASS-21)

Background information, as listed below, will be collected in order to try and identify demographic and disease related details which may affect the level of psychological impact for IBD patients:

  1. Age
  2. Ethnicity
  3. Postcode (used to calculate indices of deprivation scores, using the Indices of Multiple Deprivation [IMD] tool)
  4. Disease type
  5. Medication
  6. BSG risk group

The same patients will be contacted and asked to complete the questionnaires again after 6 and 12 months to assess changes in psychological impact and relationship to societal requirements for isolation.

Semi structured interviews will be undertaken with approximately 20 participants. More may be undertaken until saturation point is reached.

Semi-structured interviews will be undertaken to provide further detail about the experience of isolation during the pandemic to explore issues to include factors which improve or worsen the experience of isolation including:

  • The effect of the isolation itself
  • The effect of variations in information provision
  • Concern about infection risk and its variation during the period of "lock-down"
  • Delays to presentation with flare symptoms

研究の種類

観察的

入学 (予想される)

232

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Sheffield、イギリス、S10 2JF
        • 募集
        • Sheffield Teaching Hospitals NHS FT
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

16年歳以上 (子、大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Patients with a clinical diagnosis of IBD who are treated in the clinics of Sheffield Teaching Hosptials NHS FT

説明

Inclusion Criteria:

  • IBD Patients who utilise the IBD Clinics at Sheffield Teaching Hospitals NHS FT

Exclusion Criteria:

  • patients who are not part of the IBD clinics at STH NHS FT

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:コホート
  • 時間の展望:見込みのある

コホートと介入

グループ/コホート
high-risk group
IBD patients who were high risk of infection and were shielding
low-risk group
IBD patients who were low risk of infection and were following standard quarantine guidance
young people from affiliated study
32 IBD patients from an affiliated study

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
What impact has the isolation of patients during social isolation had in terms of psychological morbidity?
時間枠:Changes in psychological morbidity at 12 months
Psychological morbidity will be assessed through the 4 questionnaires
Changes in psychological morbidity at 12 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Have levels of psychological morbidity in young people changed from levels prior to the CoViD pandemic?
時間枠:Changes in psychological morbidity at 12 months
psychological morbidity will be assessed via comparison of questionnaires from affiliated study against the time points of this study
Changes in psychological morbidity at 12 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • スタディチェア:Alan Lobo, MD、Sheffield Teaching Hospitals NHS FT

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2020年6月30日

一次修了 (予想される)

2022年6月30日

研究の完了 (予想される)

2022年6月30日

試験登録日

最初に提出

2020年7月24日

QC基準を満たした最初の提出物

2020年7月27日

最初の投稿 (実際)

2020年7月28日

学習記録の更新

投稿された最後の更新 (実際)

2020年7月28日

QC基準を満たした最後の更新が送信されました

2020年7月27日

最終確認日

2020年7月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • STH21414

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

no IPD will be shared with other researchers

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

3
購読する